Precision and Personalized Medicine in Pharma – Thematic Intelligence
All the vital news, analysis, and commentary curated by our industry experts.
Precision and Personalized Medicine in Pharma Thematic Report Overview
Precision and personalized medicine have already begun to reshape disease treatment paradigms and the provision of healthcare. Improved patient outcomes, increased quality of life, reduced financial and time expenditure of disease management with curative therapies, and a shift from reactive to proactive care are all driving investment in R&D in this space.
The precision and personalized medicine in pharma thematic intelligence report provides a focused chapter on the key healthcare, technology, macroeconomic, and regulatory trends impacting precision and personalized medicine. The report also reviews how these trends will accelerate or hinder precision and personalized medicine.
|Market Size (2022)||$8 billion|
|Key Trend||· Healthcare
|Value Chain||· Diagnostics
|Leading Public Companies||· Agilent Technologies
· Alaunos Therapeutics
· Alnylam Pharmaceuticals
|Leading Private Companies||· Acepodia
· Certis Oncology Solutions
· Complement Therapeutics
|Enquire & Decide||Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.|
Precision and Personalized Medicine in Pharma – Trends
The main trends shaping the personalized and precision medicine theme over the next 12 to 24 months are healthcare, technology, macroeconomic, and regulatory.
Healthcare trends: Gene therapy, cell therapy, and the success of RNA-based therapeutics are some of the key healthcare trends shaping the personalized and precision medicine theme.
Technology trends: Advancements in Big data analytics, AI, and digital twins are some of the key technology trends accelerating the growth of precision and personalized medicine.
Macroeconomic trends: Challenges such as drug prices, market access, and inflation are hindering the development and adoption of precision and personalized medicine. Additionally, M&A’s and the rising influence of China in the market are some of the key macroeconomic trends shaping the personalized and precision medicine theme.
Regulatory trends: Regulation of precision and personalized medicines and challenges in drug reimbursement are some of the key macroeconomic trends shaping the personalized and precision medicine theme.
Precision and Personalized Medicine in Pharma – Industry Analysis
The precision and personalized medicine market was valued at $8 billion in 2022. The market is expected to achieve a CAGR of more than 43% between 2022 and 2029. In 2022, antisense oligonucleotides were the largest segment and had the highest number of marketed drugs. The major growth in this field will be driven by the forecast growth in sales of Legend Biotech’s Carvykti and BMS’s Breyanzi (lisocabtagene maraleucel), as well as the expected approval of new drugs.
Global Precision and Personalized Medicine Market Revenue Segmented by Products and Services 2022-2029 ($ Billion)
For more insights into the precision and personalized medicine in pharma market forecast, download a free report sample
Precision and Personalized Medicine in Pharma - Value Chain Analysis
The precision and personalized medicine value chain is split into five segments which are diagnostics, therapeutics, and services.
Diagnostics: Precision and personalized medicines are established on a patient’s specific biomarkers, whether they are genetic, epigenetic, proteomic, metabolomic, digital, or otherwise. Diagnostic biomarkers, which detect the presence of a disease or a predisposition towards a disease; prognostic biomarkers, which identify the likelihood of disease progression or recurrence; and predictive biomarkers, which predict a patient’s response to a particular therapy, are all fundamental in tailoring treatment.
Precision and Personalized Medicine Value Chain Analysis
For more insights into the precision and personalized medicine value chain, download a free report sample
Leading Precision and Personalized Medicine Public Companies
Some of the leading public pharma companies currently deploying precision and personalized medicine are:
- Agilent Technologies
- Alaunos Therapeutics
- Alnylam Pharmaceuticals
Leading Precision and Personalized Medicine Private Companies
Some of the leading private pharma companies currently deploying precision and personalized medicine are:
- Certis Oncology Solutions
- Complement Therapeutics
To know more about the leading precision and personalized medicine companies, download a free report sample
Pharma Sector Scorecard
At GlobalData, we use a scorecard approach to predict tomorrow’s leading companies within each sector. Our sector scorecard has three screens: a thematic screen, a valuation screen, and a risk screen.
- The thematic screen ranks companies based on overall leadership in the 10 themes that matter most to their industry, generating a leading indicator of future performance.
- The valuation screen ranks our universe of companies within a sector based on selected valuation
- The risk screen ranks companies within a particular sector based on overall investment risk.
Pharma Sector Scorecard – Thematic Screen
To know more about the sector scorecards, download a free report sample
- A focused chapter on the key healthcare, technology, macroeconomic, and regulatory trends impacting precision and personalized medicine, and a review of how these trends will accelerate or hinder precision and personalized medicine.
- Industry analysis and market forecast for different therapies within precision and personalized medicine up to 2029.
- Case studies provide in-depth insight into some of the most recent and most influential developments in precision and personalized medicine, from recently approved gene therapies to new AI platforms to accelerate the development of new personalized drugs.
- Review of leaders and disruptors across the precision and personalized medicine value chain, covering diagnostics, therapeutics, and services.
- Thematic scorecard for drug development ranking companies on their investment in the top ten themes impacting the industry, one of which being precision and personalized medicine.
Reasons to Buy
- Understand the key trends accelerating or hindering the precision and personalized medicine space.
- See market forecasts for different therapies within precision and personalized medicine up to 2029.
- Understand recent and influential developments in precision and personalized medicine.
- Review of leaders and disruptors across the precision and personalized medicine value chain.
Thermo Fisher Scientific
Certis Oncology Solutions
Merck & Co
Johnson & Johnson
Bristol Myers Squibb
BrainStorm Cell Therapeutics
Charles River Laboratories
Swedish Orphan Biovitrum
Sartorius Stedim Biotech
NeoCura Bio-Medical Technology
Table of Contents
- 1. Executive Summary
- 2. Players
- 3. Thematic Briefing
- 4. Trends
- 4.1. Healthcare trends
- 4.2. Technology trends
- 4.3. Macroeconomic trends
- 4.4. Regulatory trends
- 5. Industry Analysis
- 5.1. Market size and growth forecasts
- 5.2. Deals analysis
- 5.3. Case studies
- 5.4. Social media trends
- 6. Value Chain
- 6.1. Diagnostics
- 6.2. Therapeutics
- 6.3. Services
- 7. Companies
- 7.1. Public companies
- 7.2. Private companies
- 8. Drug Development Scorecard
- 9. Abbreviations
- 10. Further Reading
- 10.1. GlobalData reports
- 10.2. Bibliography
- 11. About the Authors
- 12. Our Thematic Research Methodology
- 13. About GlobalData
- 14. Contact Us
Frequently asked questions
What was the size of the precision and personalized medicine market in 2022?
The precision and personalized medicine market was valued at $8 billion in 2022.
What is the precision and personalized medicine market growth rate?
The precision and personalized medicine market is expected to grow at a CAGR of 43% between 2022 and 2029.
Who are the leading public companies associated with precision and personalized medicine themes?
Some of the leading public pharma companies associated with precision and personalized medicine themes are Agilent Technologies, Alaunos Therapeutics, and Alnylam Pharmaceuticals.
Who are the leading private companies associated with precision and personalized medicine themes?
Some of the leading private companies associated with precision and personalized medicine themes are Acepodia, Certis Oncology Solutions, and Complement Therapeutics.
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.